Live Breaking News & Updates on Trialcap Fund

PRESS RELEASE – INSIDE INFORMATION Biosenic signs term sheet with SPRIM Global Investments (TrialCap fund) for up to USD 8 million debt financing and USD 800,000 equity investment as a first decisive, financing step towards a Phase 3 clinical trial for its ground-breaking auto-immune medication, a first-in-class drug oral arsenic salt. Mont-Saint-Guibert, Belgium, December 6, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious aut ....

Mont Saint Guibert , Waals Gewest , Science Park , Singapore General , France General , Trialcap Pte , Ghislaine Gasparetto , Neil Hunter Michelle Boxall , International Media Enquiries , Trialcap Fund , Rd Service , Clinical Research Organization , Global Investment Company , Ib Communications , Euronext Brussels , Term Sheet , Graft Versus Host Disease , Chief Executive Officer , Investment Company , Louvain La Neuve Science Park , Mesenchymal Stromal Cells , Chief Executive , Media Enquiries , French Investor Enquiries , Sprim Global Investments , Arsenic Trioxide ,